Vitamin C plays an essential role as a cofactor involved in the enzymatic biosynthesis of collagen, catecholamine, and peptide neurohormones and antioxidant and free radical scavengers to detoxify free radicals in the retina and brain.
Vitamin C is present in retinal and brain tissues at high concentrations compared with other organs and there is a greater than 10-fold gradient between the concentration of ascorbic acid (AA) in the retina and brain tissues and blood. 2, 3) Recent reports indicate that vitamin C is mainly transported across the blood-retinal barrier (BRB) and -brain barrier (BBB) as dehydroascorbic acid (DHA) via a facilitative glucose transporter, GLUT1, and accumulates as AA in the retina and brain. [4] [5] [6] DHA, which is an oxidized form of AA, is present at a concentration of 10 mM in rat and human plasma. 7, 8) To maintain a high concentration of AA in the retina and brain, GLUT1 at the BRB and BBB supplies DHA to the retina and brain as well as D-glucose under normal conditions. Thus, one hypothesis to explain its action in diabetes mellitus is that hyperglycemia inhibits the supply of DHA to the retina and brain because of competitive inhibition of D-glucose for DHA transport via GLUT1.
The purpose of this study was to evaluate how the DHA transport to the retina and brain changes under hyperglycemic conditions by using integration plot analysis in streptozotocin-induced diabetic and normal rats.
MATERIALS AND METHODS

Animals
Male Wistar rats at 3 weeks of age (body weights: 50-55 g) were purchased from SLC (Shizuoka, Japan). The investigations using rats described in this report conformed to the provisions of the Animal Care Committee, Toyama Medical and Pharmaceutical University ( Animal Model of Diabetes Melitus Rats at 3 weeks of age were randomly assigned to become diabetic (nϭ5) or to remain non-diabetic controls (nϭ5). Diabetes was induced by the injection of a freshly prepared solution of streptozotocin in citrate buffer (pH 4.5) at a dose of 45 mg/kg into the tail vein, whereas non-diabetic control rats were treated with citrate buffer alone. A sample of blood was obtained from this vein over a period from 1 to 3 weeks after streptozotocin injection for measurement of the blood D-glucose concentrations to confirm the presence of hyperglycemia. Blood glucose concentrations were determined by the glucoseoxidase method (Nipro Freestyle, Osaka, Japan).
Determination of Influx Permeability Clearance The rats were anesthetized with an intramuscular injection of ketamine-xylazine (1.22 mg xylazine and 125 mg ketamine/kg) and then [ 14 C]DHA (5 mCi/rat, approximately 200 mmol DHA in 200 ml/head) was injected via the femoral vein. At the times designated (0.5, 1, 3 or 5 min) after administration, rats were sacrificed and the plasma and tissues were removed. Tissue sampling and determination of radioactivity were performed as described in a previous report.
5) The apparent influx permeability clearance (K in ) of [ 
where C p (t) (dpm/ml) and V i (ml/g tissue) represent the plasma concentration at time t and the rapidly equilibrated distribution volume of [ 14 C]DHA, respectively; AUC(t) (dpm · min/ml) is the area under the plasma concentration time curve of [ Data Analysis Unless otherwise indicated, all data represent meansϮS.E.M. An unpaired, two-tailed Student's ttest was used to determine the significance of differences between two group means.
RESULTS
The blood D-glucose concentration was 25.6Ϯ0.4 mM (nϭ5) in the streptozotocin-induced diabetic rats with a 3-week duration of diabetes, and 4.42Ϯ0.07 mM (nϭ10) and 8.01Ϯ0.32 mM (nϭ5) at 3 and 6 weeks age, respectively, in non-diabetic control rats. It was increased 3.2-fold in diabetic rats compared with controls. The final body weights were not appreciably increased in the streptozotocin-induced diabetic rats with a 3-week duration of diabetes (97.6Ϯ4.0 g, nϭ5), whereas the final body weights of the control rats increased to 215Ϯ5 g (nϭ5) from 52.0Ϯ1.0 g (nϭ10).
The DHA transport into the retina and brain across the BRB and BBB was evaluated and compared with the heart by means of the integration plot analysis after intravenous administration of [
14 C]DHA to the streptozotocininduced diabetic and normal rats (Fig. 1) . The K in retina of [ 14 C]DHA in diabetic and normal rats was determined to be 841Ϯ243 ml/(min · g retina) and 2.44ϫ10 3 Ϯ0.05ϫ10 3 ml/(min · g retina), respectively. The K in brain of [ 14 C]DHA in diabetic and normal rats was determined to be 49.1Ϯ 11.5 ml/(min· g brain) and 309Ϯ53 ml/(min· g brain), respectively. The K in retina and K in brain of [ 14 C]DHA in diabetic rats was reduced by 65.5% and 84.1%, respectively, compared with normal rats, whereas no significant difference was found between the K in heart of diabetic and normal rats [50.0Ϯ12.6 ml/(min· g heart) and 49.7Ϯ15.1 ml/(min· g heart), respectively].
DISCUSSION
The present study produces, for the first time, in vivo evidence that hyperglycemia reduces blood-to-retina and -brain transport of [ 14 C]DHA across the BRB and BBB (Fig. 1) . DHA is transported by GLUT1, which is expressed at the luminal (blood) and abluminal (retina or brain) side of the inner BRB (retinal capillary endothelial cells), outer BRB (retinal pigment epithelial cells), and BBB (brain capillary endothelial cells). [9] [10] [11] On the other hand, there was only a small difference between the K in heart of diabetic and normal rats since there is no barrier in the heart. Therefore, DHA transport from blood to the retina and brain decreases with increasing blood D-glucose concentration because of prevention of DHA uptake by GLUT1 at the BRB and BBB. We previously reported that [ 14 C]DHA uptake by a retinal endothelial cell line (TR-iBRB2 cells) expressing GLUT1 was inhibited by D-glucose in a concentration-dependent manner with a 50% inhibition of 5.56 mM. 5) Although DHA transport via GLUT1 at the BRB and BBB is not completely inhibited under normal conditions, it is markedly inhibited under diabetic conditions. Indeed, the K in retina and K in brain of [ 14 C]DHA in diabetic rats was reduced by 65.5% and 84.1%, respectively, compared with normal rats (Fig. 1) . Badr et al. reported that streptozotocin-induced diabetic rats with a 8-week duration of diabetes exhibited reduced GLUT1 expression by Ͼ60% at the inner BRB compared with nondiabetic rats, but this resulted in no reduction in GLUT1 expression at the outer BRB and BBB. 12) On the other hand, Pardridge et al. reported that streptozotocin-induced diabetic rats with a 1-week duration of diabetes exhibited reduced GLUT1 expression by 77% at the BBB compared with nondiabetic rats. 13) Although down-regulation of GLUT1 expression is not constant under different experimental conditions, reduction of GLUT1 expression at the BRB and BBB cannot be ruled out as a contributor to DHA transport to the retina and brain in the present study. When the GLUT1 expression at the BBB was reduced by 77%, the GLUT1 transport activity at the BBB was only reduced by 44%. 13) Therefore, hyperglycemia plays a role in reducing the supply of DHA to the brain and retina even although GLUT1 is down-regulated.
Since there is no compensatory down-regulation of GLUT1 at the inner BRB in an animal model and in patients with long-standing diabetes, 14, 15) reduction of DHA transport by hyperglycemia is more involved in the chronic hyperglycemia of long-standing diabetes than acute hyperglycemia. The total vitamin C concentration in the retina and brain is not changed in short-term diabetics, since AA/DHA could be recycled by glutathione. 16, 17) However, the chronic hyperglycemia of long-standing diabetes is associated with "glucose toxicity" leading to oxidative stress resulting from increased production of reactive oxygen species and, often, down-regulation of anti-oxidative defense mechanisms. 18, 19) Hyperglycemia reduces DHA transport via GLUT1 at the BRB and BBB. DHA is reconverted into AA in the retina and brain. 4, 5) Reduction of the supply of AA to the retina and brain through competition of D-glucose and DHA for a common transporter would reduce the antioxidant and could lead to accumulation of reactive oxygen species followed by acti- vation of the protein kinase C and aldose reductase pathway and advanced glycation end-products in the retina and brain. 20) Moreover, AA is a required cofactor for several intracellular hydroxylases, including proline hydroxylase and dopamine-b-hydroxylase. 1) Therefore, chronic hyperglycemia appears to cause disregulation of catecholamine metabolism in the retina and brain. In the light of these findings, diabetic patients may experience enhanced oxidative stress and metabolic perturbations in the retina and brain by reducing the influx transport of DHA, leading to the hypothesis that diabetic retinopathy and encephalopathy involve a dysfunction of DHA influx transport at the BRB and BBB.
In conclusion, hyperglycemia reduces blood-to-retina and -brain transport of DHA across the BRB and BBB. These findings provide important information to help us understand the implications of increasing the antioxidant potential in the retina and brain.
